Development of a Novel DPI: Opportunities and Constraints

A case study in the development of a novel dry powder inhaler (DPI) that puts the patient at the centre of the design process.

By Guillaume Brouet and Christophe Fagot at Valois Pharma (December 2009)

Keywords: Novel DPI, dry poder Inhaler, therapy, Brouet, Fagot, Valois Pharma, In Vivo, In Vitro,

View full article    |    Back to Ingredients, Formulations and Finishing section